Obstetrics and Gynecology Clinics of North America
FETAL BIOPHYSICAL PROFILE
Section snippets
THEORETIC BASIS OF THE FETAL BIOPHYSICAL PROFILE
The fetal central nervous system initiates and regulates fetal biophysical activity by the production of efferent nervous traffic that originates in specialized centers throughout the brain and travels via the peripheral nerve network to the effector apparatus in the periphery. Thus, the muscles that control fetal movement, tone, and breathing may be viewed as transducers of the central signal source—the brain. Interruption of the supply of oxygen to neuronal tissue results in a cessation of
METHOD FOR FETAL BIOPHYSICAL PROFILE SCORE
The BPS is constructed from data obtained from two sources: (1) the results of observation by a dynamic ultrasound method of the presence or absence of fetal breathing movements, gross body movements, tone, and amniotic fluid volume; and (2) the results of the fetal heart rate responses to fetal movements as recorded using an external method of continuous fetal heart rate recording (Table 1). Although there is no theoretical reason to order these two observations in any particular way, there is
WHEN TO START TESTING
Two general clinical guidelines are followed in determining when to begin antepartum BPS surveillance in the high-risk fetus. First, testing should not be instituted until active intervention for fetal compromise is possible. Initially, fetal BPS was used as a method for the detection of fetal asphyxia. When abnormal results were encountered, the recommended action was delivery. The degree of abnormality of the score necessary to trigger this response varied by gestational age such that the
FREQUENCY OF TESTING
The frequency of testing should be based on the clinical circumstances for each individual case and can be expected to vary widely between and even within cases. The usual starting point is to plan for a testing frequency of once per week in most referred high-risk pregnancies and at least twice per week in the pregnancy at or beyond 294 completed days (>42 weeks) and in the insulin-dependent diabetic pregnancy. The testing frequency should be adapted to the clinical situation. The more
CLINICAL MANAGEMENT BASED ON THE TEST SCORE
The goal of antepartum fetal assessment is not to treat the test result but rather to treat the fetus and mother. Accordingly, clinical management based on BPS results must include a consideration of the full spectrum of maternal and fetal clinical information (Tables 2 and 3).
In general, a normal BPS (defined as 10/10, 8/10 with normal amniotic fluid, or 8/8 without NST) may be interpreted as reliable evidence that the fetus is not compromised at the time of testing. A normal BPS is also a
Selective Use of the Nonstress Test: Biophysical Profile Score of 8/8
In the early clinical application of fetal BPS in referred high-risk pregnancies, it became evident that when the four dynamic ultrasound variables were normal, the probability of encountering an abnormal (nonreactive) NST was exceedingly small.16 Furthermore, the test accuracy parameters of the four ultrasound-monitored variables when normal (BPP 8/8, no NST) were identical to that reported for the normal fetal BPP score (BPP 10/10, NST included).18 In contrast, when one or more of the
BIOPHYSICAL PROFILE SCORE AND FETAL CORD BLOOD ACID-BASE AND pH VALUES
The relationship between the BPS and fetal blood gas and pH has been studied in several clinical settings. A highly significant direct linear correlation has been reported between the BPS and cord blood obtained at delivery.20, 23, 36 Vintzileos and associates36 compared cord blood gas and pH values with the BPS results in samples collected at cesarean section before the onset of labor in 124 patients and reported a highly significant direct linear correlation with both arterial and venous pH.
CLINICAL APPLICATION, PREDICTIVE ACCURACY, AND IMPACT ON OUTCOME OF FETAL BIOPHYSICAL PROFILE SCORING
Fetal BPS is used to predict the presence or absence of fetal asphyxia. Both the gestational age at which testing is begun and the testing frequency vary according to maternal and fetal risk factors. In general, testing is not begun at a gestational age before which intervention for fetal reasons is contemplated. This age varies among centers. At the author's facility, testing is not started before 26 weeks' gestation, except in clinical circumstances in which fetal therapy is possible (e.g.,
BIOPHYSICAL PROFILE AND CEREBRAL PALSY
Cerebral palsy is defined as a nonprogressive neurologic abnormality affecting the regulation of muscles controlling posture, tone, and voluntary movements. The disorder occurs as a result of an insult in the perinatal period. Perinatal asphyxia in the antepartum, intrapartum, or neonatal period is a recognized cause of cerebral palsy.
Because the BPS predicts the presence or absence of fetal asphyxia, it follows that a relationship may exist between the last BPS result and the risk for cerebral
ADULT SEQUELAE OF FETAL ADAPTATION TO ASPHYXIA: THE ALPHA-OMEGA CONCEPT
The fetus is superbly adapted to its intrauterine environment. Remarkable adaptation mechanisms allow the fetus to cope and survive with asphyxia, at least in the short term, and usually for a sufficient time to trigger parturition. Two of these adaptive compensatory responses— the cessation of all nonessential acute biophysical activities and the redistribution of cardiac output away from nonessential organs to life-essential fetal organs (i.e., placenta, heart, brain, and adrenals)—form the
References (37)
- et al.
Ultrasound evaluation of amniotic fluid. I. The relationship of marginal and decreased amniotic fluid volume to perinatal outcome
Am J Obstet Gynecol
(1984) - et al.
A prospective multi-institutional study of antepartum fetal heart rate monitoring. I. Risk of perinatal morbidity and mortality according to antepartum fetal heart rate test results
Am J Obstet Gynecol
(1982) - et al.
The role of nonstress tests, fetal biophysical profile and contraction stress tests in the outpatient management of insulin requiring diabetic pregnancies
Am J Obstet Gynecol
(1984) - et al.
Fetal breathing movements and the abnormal contraction stress tests
Am J Obstet Gynecol
(1979) - et al.
Antepartum fetal evaluation: Development of a fetal biophysical profile score
Am J Obstet Gynecol
(1980) - et al.
Fetal biophysical profile scoring. VI. Correlations with antepartum umbilical venous pH
Am J Obstet Gynecol
(1993) - et al.
Fetal biophysical profile scoring: The selective use of the non-stress test
Am J Obstet Gynecol
(1987) - et al.
Fetal assessment based on the fetal biophysical profile score: Experience in 19,921 referred high-risk pregnancies. II. The false-negative rate by frequency and etiology
Am J Obstet Gynecol
(1987) - et al.
Fetal assessment based on fetal biophysical profile scoring: Experience in 12,620 referred high-risk pregnancies. I. Perinatal mortality by frequency and etiology
Am J Obstet Gynecol
(1985) - et al.
Qualitative amniotic fluid volume determination by ultrasound: Antepartum detection of intrauterine growth retardation
Am J Obstet Gynecol
(1981)
Fetal assessment by fetal biophysical profile score. VI. The incidence of cerebral palsy among tested and non-tested perinates
Am J Obstet Gynecol
Impaired fetal growth and atherosclerosis of carotid and peripheral arteries
Lancet
Superiority of the four-quadrant sum over the single-deepest-pocket technique in ultrasonographic identification of abnormal amniotic fluid volumes
Am J Obstet Gynecol
Perinatal outcome with the modified biophysical profile
Am J Obstet Gynecol
Clinical experience with the oxytocin challenge test
Am J Obstet Gynecol
Relationship of fetal biophysical profile and blood gas values at cordocentesis in severely growth-retarded fetuses
Am J Obstet Gynecol
The role of real time scanning in antenatal surveillance
Am J Obstet Gynecol
Relationship between fetal biophysical activities and cord blood gas values
Am J Obstet Gynecol
Cited by (86)
Antepartum Fetal Evaluation
2016, Obstetrics: Normal and Problem PregnanciesManagement of Cardiovascular Diseases During Pregnancy
2014, Current Problems in CardiologyAntepartum Fetal Surveillance and Optimal Timing of Delivery in Diabetic Women: A Narrative Review
2024, Journal of Clinical Medicine
Address reprint requests to Frank A. Manning, MD, Department of Obstetrics and Gynecology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Belfer Room 512, Bronx, NY 10461
- *
Department of Obstetrics and Gynecology, Albert Einstein College of Medicine, Bronx, New York